INTELLIA THERAPEUTICS INC (NTLA) Stock Balance Sheet
NASDAQ:NTLA - Nasdaq - US45826J1051 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 120.50M | 226.75M | 523.50M | 123.40M | 160.00M | |||
| Marketable Securities | 537.62M | 685.48M | 669.10M | 625.30M | 437.40M | |||
| Receivables | 8.85M | 36.46M | 3.80M | 2.00M | 2.10M | |||
| Other Current Assets | 43.93M | 49.65M | 20.40M | 18.60M | 17.00M | |||
| Total Current Assets | 710.90M | 998.33M | 1.22B | 769.30M | 616.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 129.09M | 148.13M | 161.00M | 100.10M | 55.10M | |||
| Investments And Advances | 316.52M | 136.43M | 101.80M | 395.50M | N/A | |||
| Other Non-Current Assets | 16.84M | 18.08M | 40.50M | 29.60M | 4.70M | |||
| Total Non-Current Assets | 462.45M | 302.65M | 303.30M | 525.20M | 59.80M | |||
| TOTAL ASSETS | 1.17B | 1.30B | 1.52B | 1.29B | 676.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 70.38M | 85.62M | 77.60M | 52.40M | 31.30M | |||
| Accounts Payable | 13.14M | 7.45M | 5.20M | 9.70M | 10.50M | |||
| Other Current Liabilities | 22.16M | 22.14M | 43.80M | 63.80M | 22.50M | |||
| Total Current Liabilities | 105.68M | 115.21M | 126.60M | 125.80M | 64.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 105.05M | 135.60M | 158.00M | 128.40M | 85.00M | |||
| Total Non-Current Liabilities | 105.05M | 135.60M | 157.90M | 128.40M | 85.00M | |||
| TOTAL LIABILITIES | 210.74M | 250.81M | 284.50M | 254.20M | 149.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.05B | -1.66B | -1.18B | -703.00M | -435.10M | |||
| Additional Paid In Capital | 3.01B | 2.71B | 2.42B | 1.75B | 962.20M | |||
| Common Shares | 10.00K | 9.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 3.30M | -2.26M | -7.50M | -2.60M | 0.00 | |||
| Shares Outstanding | 101.80M | 93.00M | 87.10M | 74.50M | 66.20M | |||
| Tangible Book Value per Share | 9.46 | 11.29 | 14.19 | 13.96 | 7.96 | |||
| Total Shareholders' Equity | 962.62M | 1.05B | 1.24B | 1.04B | 527.10M | |||
| TOTAL LIABILITIES AND EQUITY | 1.17B | 1.30B | 1.52B | 1.29B | 676.30M | |||
| Statistics | ||||||||
| Current Ratio | 6.73 | 8.67 | 9.61 | 6.12 | 9.59 | |||
| Return On Assets (ROA) | -74.26% | -36.99% | -31.19% | -20.69% | -19.85% | |||
| Return On Equity (ROE) | -90.52% | -45.82% | -38.38% | -25.75% | -25.47% | |||
All data in USD , ROIC based on taxRate of 0.21